自拟养血消风润燥方治疗血虚风燥型慢性湿疹临床观察

Clinical Observation on Self-made Nourishing Blood and Dispelling Wind for Moisturizing Dryness Recipe in Treating Chronic Eczema of Blood-deficiency and Wind-dryness

目的探讨自拟养血消风润燥方治疗血虚风燥型慢性湿疹临床疗效。方法选取我院2015年4月—2016年5月门诊治疗血虚风燥型慢性湿疹84例,将其随机分为治疗组和对照组,每组42例,治疗组给予自拟养血消风润燥方治疗,对照组给予氯雷他定片治疗,14天为一个疗程,两组均治疗2个疗程,比较两组的临床疗效、治疗前后主要症状积分、不良反应及复发率情况。结果治疗组总有效率为88.10%,对照组为69.05%,两组比较差异具有统计学意义(P<0.05),治疗后两组主要症状积分均明显改善,且治疗组优于对照组(P<0.05);治疗组不良反应及复发率均低于对照组(P<0.05)。结论自拟养血消风润燥方治疗血虚风燥型慢性湿疹能有效改善患者临床症状,提高患者的生活质量,降低不良反应和复发率的发生,值得临床借鉴。

Objective To investigate the clinical effect of self-made nourishing blood and dispelling wind for moisturizing dryness recipe in treating chronic eczema of blood-deficiency and wind-dryness,and to further guide clinic medicine. Methods 84 cases of patients with chronic eczema of blood-deficiency and wind-dryness in our hospital from April 2015 to May 2016 were randomly divided into treatment and control groups,and each group had 42 cases. The treatment group received self-made nourishing blood and dispelling wind for moisturizing dryness recipe. The control group received loratadine tablets. 14 days was a course of treatment,and both groups received 2 courses of treatment. The clinical effect,the main symptom scores before and after treatment,and recurrence rate of adverse reactions of two groups was compared. Results The total effective rate of the treatment group and the control group was 88. 10% and 69. 05%,respectively,and the difference was statistically significant（P 0. 05）. After treatment,the improvement on the main symptom scores of the treatment group was significantly better than that of the control group（P 0. 05）. The adverse reactions and relapse rates of the treatment group were lower than those of the control group（P 0. 05）. Conclusion The self-made nourishing blood and dispelling wind for moisturizing dryness recipe in treating chronic eczema of blood-deficiency and wind-dryness can effectively improve the clinical symptoms and quality of life of patients,reduce the recurrence rate of adverse reactions,and is worthy of reference.